Delivering Value & Access solutions for Market Access, Pricing, HEOR and Medical Affairs organizations
Access Strategies
Optimize patient access and reimbursement through evidence-based and innovative strategic thinking
Value Strategies
Ensuring you have the best in class value demonstration strategies and dissemination plan
Management Consulting
Unlocking your full organizational potential
Delivering Value & Access solutions for Market Access, Pricing, HEOR and Medical Affairs organizations
AESARA is a boutique consulting firm with biopharma DNA, who can help you optimize patient access and reimbursement through evidence-based and innovative strategic thinking.
Description
AESARA's core offerings are below:
VALUE & ACCESS CONSULTING
- Market Access & Value Strategy
- Payer Research & Advisory Boards
- Value Proposition
- Value Communication Tools
- Inflation Reduction Act (IRA)/PDAB Readiness
- Health Technology Assessment (HTA) Submissions
- Endpoint Strategy
- Value-based Pricing/Agreements
- Time & Materials (T&M) Support & Staff Extenders
- Launch Planning
- HTA Landscape and Competitive Assessments
- Coding, Billing and Reimbursement Strategy
HEOR CONSULTING
- Integrated Evidence Generation Planning (IEGP)
- Comprehensive Patient Perspective
- Literature Reviews
- Global Value and AMCP Dossiers
- Economic Modeling
- Real-World Evidence (RWE) Strategy & Study Design
- Evidence Gap Analyses
- Clinical Outcome Assessment (COA) Strategy
- Retrospective Chart Reviews
- ICER Readiness
- Delphi Panels
MANAGEMENT CONSULTING
- Education & Training
- Vision Casting
- Organization Transformation
- Organization Design
- Team Competency Development
- Key Performance Indicators (KPIs) Development
- Function Branding and Positioning
- Internal Communications
- Process Design and Improvement (e.g., Operationalizing FDA Payer Guidance, Patient Experience Data Communications Framework)
EUROPE OFFERINGS
- EU JCA PICO prediction & Dossier development
- Lifecycle Management (LCM) Strategy
- EU JCA Process & Governance Design
VALUE & ACCESS CONSULTING
- Market Access & Value Strategy
- Payer Research & Advisory Boards
- Value Proposition
- Value Communication Tools
- Inflation Reduction Act (IRA)/PDAB Readiness
- Health Technology Assessment (HTA) Submissions
- Endpoint Strategy
- Value-based Pricing/Agreements
- Time & Materials (T&M) Support & Staff Extenders
- Launch Planning
- HTA Landscape and Competitive Assessments
- Coding, Billing and Reimbursement Strategy
HEOR CONSULTING
- Integrated Evidence Generation Planning (IEGP)
- Comprehensive Patient Perspective
- Literature Reviews
- Global Value and AMCP Dossiers
- Economic Modeling
- Real-World Evidence (RWE) Strategy & Study Design
- Evidence Gap Analyses
- Clinical Outcome Assessment (COA) Strategy
- Retrospective Chart Reviews
- ICER Readiness
- Delphi Panels
MANAGEMENT CONSULTING
- Education & Training
- Vision Casting
- Organization Transformation
- Organization Design
- Team Competency Development
- Key Performance Indicators (KPIs) Development
- Function Branding and Positioning
- Internal Communications
- Process Design and Improvement (e.g., Operationalizing FDA Payer Guidance, Patient Experience Data Communications Framework)
EUROPE OFFERINGS
- EU JCA PICO prediction & Dossier development
- Lifecycle Management (LCM) Strategy
- EU JCA Process & Governance Design
